These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

411 related items for PubMed ID: 19101766

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Methods of detection of first recurrence in patients with stage I/II primary cutaneous melanoma after sentinel lymph node biopsy.
    Moore Dalal K, Zhou Q, Panageas KS, Brady MS, Jaques DP, Coit DG.
    Ann Surg Oncol; 2008 Aug; 15(8):2206-14. PubMed ID: 18512102
    [Abstract] [Full Text] [Related]

  • 3. Follow-up recommendations for patients with American Joint Committee on Cancer Stages I-III malignant melanoma.
    Poo-Hwu WJ, Ariyan S, Lamb L, Papac R, Zelterman D, Hu GL, Brown J, Fischer D, Bolognia J, Buzaid AC.
    Cancer; 1999 Dec 01; 86(11):2252-8. PubMed ID: 10590365
    [Abstract] [Full Text] [Related]

  • 4. [Detection of the first recurrence in patients with melanoma: three quarters by the patient, one quarter during outpatient follow-up].
    Francken AB, Thompson JF, Bastiaannet E, Hoekstra HJ.
    Ned Tijdschr Geneeskd; 2008 Mar 08; 152(10):557-62. PubMed ID: 18402322
    [Abstract] [Full Text] [Related]

  • 5. Patterns of first-recurrence and post-recurrence survival in patients with primary cutaneous melanoma after sentinel lymph node biopsy.
    Dalal KM, Patel A, Brady MS, Jaques DP, Coit DG.
    Ann Surg Oncol; 2007 Jun 08; 14(6):1934-42. PubMed ID: 17406951
    [Abstract] [Full Text] [Related]

  • 6. Detection of first relapse in cutaneous melanoma patients: implications for the formulation of evidence-based follow-up guidelines.
    Francken AB, Shaw HM, Accortt NA, Soong SJ, Hoekstra HJ, Thompson JF.
    Ann Surg Oncol; 2007 Jun 08; 14(6):1924-33. PubMed ID: 17357855
    [Abstract] [Full Text] [Related]

  • 7. Costs of the detection of metastases and follow-up examinations in cutaneous melanoma.
    Leiter U, Marghoob AA, Lasithiotakis K, Eigentler TK, Meier F, Meisner C, Garbe C.
    Melanoma Res; 2009 Feb 08; 19(1):50-7. PubMed ID: 19430406
    [Abstract] [Full Text] [Related]

  • 8. Routine restaging PET/CT and detection of initial recurrence in sentinel lymph node positive stage III melanoma.
    Baker JJ, Meyers MO, Frank J, Amos KD, Stitzenberg KB, Ollila DW.
    Am J Surg; 2014 Apr 08; 207(4):549-54. PubMed ID: 24674829
    [Abstract] [Full Text] [Related]

  • 9. Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.
    Nowecki ZI, Rutkowski P, Kulik J, Siedlecki JA, Ruka W.
    Br J Dermatol; 2008 Sep 08; 159(3):597-605. PubMed ID: 18616789
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Microscopic satellitosis in patients with primary cutaneous melanoma: implications for nodal basin staging.
    Kimsey TF, Cohen T, Patel A, Busam KJ, Brady MS.
    Ann Surg Oncol; 2009 May 08; 16(5):1176-83. PubMed ID: 19224283
    [Abstract] [Full Text] [Related]

  • 12. Histopathologic characteristics, recurrence patterns, and survival of 129 patients with desmoplastic melanoma.
    Posther KE, Selim MA, Mosca PJ, Stanley WE, Johnson JL, Tyler DS, Seigler HF.
    Ann Surg Oncol; 2006 May 08; 13(5):728-39. PubMed ID: 16538415
    [Abstract] [Full Text] [Related]

  • 13. Classification and staging of melanoma.
    Gershenwald JE, Buzaid AC, Ross MI.
    Clin Lab Med; 2000 Dec 08; 20(4):785-815. PubMed ID: 11221515
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Routine follow-up by magnetic resonance imaging does not improve detection of resectable local recurrences from colorectal cancer.
    Titu LV, Nicholson AA, Hartley JE, Breen DJ, Monson JR.
    Ann Surg; 2006 Mar 08; 243(3):348-52. PubMed ID: 16495699
    [Abstract] [Full Text] [Related]

  • 16. The value of routine follow-up in patients treated for carcinoma of the vulva.
    Oonk MH, de Hullu JA, Hollema H, Mourits MJ, Pras E, Wymenga AN, van der Zee AG.
    Cancer; 2003 Dec 15; 98(12):2624-9. PubMed ID: 14669281
    [Abstract] [Full Text] [Related]

  • 17. Melanoma staging: facts and controversies.
    Forschner A, Eigentler TK, Pflugfelder A, Leiter U, Weide B, Held L, Meier F, Garbe C.
    Clin Dermatol; 2010 Dec 15; 28(3):275-80. PubMed ID: 20541679
    [Abstract] [Full Text] [Related]

  • 18. Head and neck cutaneous melanoma: a retrospective observational study on 146 patients.
    Koskivuo IO, Kinnunen IA, Suominen EA, Talve LA, Vihinen PP, Grénman RA.
    Acta Oncol; 2009 Dec 15; 48(3):460-7. PubMed ID: 18843562
    [Abstract] [Full Text] [Related]

  • 19. Staging workup, sentinel node biopsy, and follow-up tests for melanoma: update of current concepts.
    Johnson TM, Bradford CR, Gruber SB, Sondak VK, Schwartz JL.
    Arch Dermatol; 2004 Jan 15; 140(1):107-13. PubMed ID: 14732667
    [Abstract] [Full Text] [Related]

  • 20. Hazard rates for recurrent and secondary cutaneous melanoma: an analysis of 33,384 patients in the German Central Malignant Melanoma Registry.
    Leiter U, Buettner PG, Eigentler TK, Bröcker EB, Voit C, Gollnick H, Marsch W, Wollina U, Meier F, Garbe C.
    J Am Acad Dermatol; 2012 Jan 15; 66(1):37-45. PubMed ID: 21700361
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.